Literature DB >> 22628002

Comparative effectiveness research in cancer screening programmes.

Michael Bretthauer1, Geir Hoff.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22628002     DOI： 10.1136/bmj.e2864

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  Intellectual dishonesty.

Authors:  Athol Kent
Journal:  Rev Obstet Gynecol       Date:  2012

2.  Favorable lifestyle before diagnosis associated with lower risk of screen-detected advanced colorectal neoplasia.

Authors:  Markus D Knudsen; Thomas de Lange; Edoardo Botteri; Dung-Hong Nguyen; Helge Evensen; Chloé B Steen; Geir Hoff; Tomm Bernklev; Anette Hjartåker; Paula Berstad
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

Review 3.  Different standards for healthy screenees than patients in routine clinics?

Authors:  Geir Hoff
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

Review 4.  Prediction of gastric cancer development by serum pepsinogen test and Helicobacter pylori seropositivity in Eastern Asians: a systematic review and meta-analysis.

Authors:  Teruhiko Terasawa; Hiroshi Nishida; Katsuaki Kato; Isao Miyashiro; Takaki Yoshikawa; Reo Takaku; Chisato Hamashima
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

5.  Do no harm: no psychological harm from colorectal cancer screening.

Authors:  Benedicte Kirkøen; Paula Berstad; Edoardo Botteri; Tone Lise Åvitsland; Alvilde Maria Ossum; Thomas de Lange; Geir Hoff; Tomm Bernklev
Journal:  Br J Cancer       Date:  2016-02-11       Impact factor: 7.640

6.  Psychological effects of colorectal cancer screening: Participants vs individuals not invited.

Authors:  Benedicte Kirkøen; Paula Berstad; Edoardo Botteri; Linn Bernklev; Badboni El-Safadi; Geir Hoff; Thomas de Lange; Tomm Bernklev
Journal:  World J Gastroenterol       Date:  2016-11-21       Impact factor: 5.742

7.  Lifestyle predictors for non-participation and outcome in the second round of faecal immunochemical test in colorectal cancer screening.

Authors:  Markus Dines Knudsen; Paula Berstad; Anette Hjartåker; Elisabeth Haagensen Gulichsen; Geir Hoff; Thomas de Lange; Tomm Bernklev; Edoardo Botteri
Journal:  Br J Cancer       Date:  2017-07-13       Impact factor: 7.640

8.  Optimising faecal occult blood screening:retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm.

Authors:  J Geraghty; P Butler; H Seaman; J Snowball; S Sarkar; R Blanks; S Halloran; K Bodger; C J Rees
Journal:  Br J Cancer       Date:  2014-09-16       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.